T1	Participants 341 395	Seventy-six patients with esophageal gastric carcinoma
T2	Participants 439 450	FZYLG group
T3	Participants 459 472	control group
T4	Participants 497 503	former
T5	Participants 687 700	treated group
T6	Participants 743 756	control group
T7	Participants 975 988	treated group
T8	Participants 1060 1073	control group
